Medtronic plc (MDT) stock
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 18/303% above fair value
$102.32−0.56 (-0.54%)
Close on Nov 17, 2026Market cap $130.88BP/E 25.1Yield 2.78%
Medtronic operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Medtronic's operating cash flow for the twelve months ending Jul 31, 2026 was $8.04B, up 12.4% year over year. For fiscal 2026 it was $7.33B, up 4.1% from the year before. Over ten years it grew 3.5% a year on average. The highest annual figure on record is $7.35B in fiscal 2022.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 24, 2026 | $7.33B | +4.1% |
| FY2025 | Apr 25, 2025 | $7.04B | +3.8% |
| FY2024 | Apr 26, 2024 | $6.79B | +12.4% |
| FY2023 | Apr 28, 2023 | $6.04B | -17.8% |
| FY2022 | Apr 29, 2022 | $7.35B | +17.7% |
| FY2021 | Apr 30, 2021 | $6.24B | -13.7% |
| FY2020 | Apr 24, 2020 | $7.23B | +3.2% |
| FY2019 | Apr 26, 2019 | $7.01B | +49.6% |
| FY2018 | Apr 27, 2018 | $4.68B | -31.9% |
| FY2017 | Apr 28, 2017 | $6.88B | +31.9% |
| FY2016 | Apr 29, 2016 | $5.22B | +6.4% |
| FY2015 | Apr 24, 2015 | $4.90B | -1.1% |
| FY2014 | Apr 25, 2014 | $4.96B | +0.3% |
| FY2013 | Apr 26, 2013 | $4.94B | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | $1.79B | +64.8% |
| Q4 FY2026CQ1 2026 | Apr 24, 2026 | $2.57B | +1.8% |
| Q3 FY2026CQ4 2025 | Jan 23, 2026 | $2.74B | +6.7% |
| Q2 FY2026CQ3 2025 | Oct 24, 2025 | $925.00M | -3.4% |
| Q1 FY2026CQ2 2025 | Jul 25, 2025 | $1.09B | +10.3% |
| Q4 FY2025CQ1 2025 | Apr 25, 2025 | $2.53B | -9.0% |
| Q3 FY2025CQ4 2024 | Jan 24, 2025 | $2.57B | +4.0% |
| Q2 FY2025CQ3 2024 | Oct 25, 2024 | $958.00M | +44.9% |
| Q1 FY2025CQ2 2024 | Jul 26, 2024 | $986.00M | +12.7% |
| Q4 FY2024CQ1 2024 | Apr 26, 2024 | $2.78B | +12.9% |
| Q3 FY2024CQ4 2023 | Jan 26, 2024 | $2.47B | +57.2% |
| Q2 FY2024CQ3 2023 | Oct 27, 2023 | $661.00M | -28.3% |
| Q1 FY2024CQ2 2023 | Jul 28, 2023 | $875.00M | -19.2% |
| Q4 FY2023CQ1 2023 | Apr 28, 2023 | $2.46B | +19.6% |
| Q3 FY2023CQ4 2022 | Jan 27, 2023 | $1.57B | -29.4% |
| Q2 FY2023CQ3 2022 | Oct 28, 2022 | $922.00M | -47.9% |
| Q1 FY2023CQ2 2022 | Jul 29, 2022 | $1.08B | -16.2% |
| Q4 FY2022CQ1 2022 | Apr 29, 2022 | $2.06B | +17.9% |
| Q3 FY2022CQ4 2021 | Jan 28, 2022 | $2.23B | -5.4% |
| Q2 FY2022CQ3 2021 | Oct 29, 2021 | $1.77B | -4.9% |
| Q1 FY2022CQ2 2021 | Jul 30, 2021 | $1.29B | +364.7% |
| Q4 FY2021CQ1 2021 | Apr 30, 2021 | $1.75B | +20.3% |
| Q3 FY2021CQ4 2020 | Jan 29, 2021 | $2.36B | -2.1% |
| Q2 FY2021CQ3 2020 | Oct 30, 2020 | $1.86B | -0.3% |
| Q1 FY2021CQ2 2020 | Jul 31, 2020 | $278.00M | -81.6% |
| Q4 FY2020CQ1 2020 | Apr 24, 2020 | $1.45B | -30.5% |
| Q3 FY2020CQ4 2019 | Jan 24, 2020 | $2.41B | +17.1% |
| Q2 FY2020CQ3 2019 | Oct 25, 2019 | $1.87B | +60.5% |
| Q1 FY2020CQ2 2019 | Jul 26, 2019 | $1.51B | -11.3% |
| Q4 FY2019CQ1 2019 | Apr 26, 2019 | $2.09B | +101.1% |
| Q3 FY2019CQ4 2018 | Jan 25, 2019 | $2.06B | +2.6% |
| Q2 FY2019CQ3 2018 | Oct 26, 2018 | $1.16B | +28.2% |
| Q1 FY2019CQ2 2018 | Jul 27, 2018 | $1.70B | +130.9% |
| Q4 FY2018CQ1 2018 | Apr 27, 2018 | $1.04B | -41.5% |
| Q3 FY2018CQ4 2017 | Jan 26, 2018 | $2.00B | -4.0% |
| Q2 FY2018CQ3 2017 | Oct 27, 2017 | $907.00M | -38.4% |
| Q1 FY2018CQ2 2017 | Jul 28, 2017 | $737.00M | – |
| Q4 FY2017CQ1 2017 | Apr 28, 2017 | $1.77B | – |
| Q3 FY2017CQ4 2016 | Jan 27, 2017 | $2.09B | – |
| Q2 FY2017CQ3 2016 | Oct 28, 2016 | $1.47B | – |
See a number that looks wrong?